
Tudor G. Jovin, MD
@tudorgjovin
Chair of the @CooperHospital Neuroscience Institute. Tweets are not endorsements.
ID: 1204497283779366912
10-12-2019 20:25:55
358 Tweet
5,5K Followers
213 Following



Tomorrow at 9.00 am France time SLICE - Worldwide / Next Frontiers / Workshops, co-PI's Montpellier Team Cases Caroline Arquizan lapergue Bertrand, MD, PhD Tudor G. Jovin, MD will present primary results of LASTE (randomized trial of MT in large core pts. ASPECTS 0-5). Median core = 150 ml with 56% ASPECTS 0-2.Please join us: masterandfellow.com/slice/ww


Honored to present LASTE results SLICE - Worldwide / Next Frontiers / Workshops together with Montpellier Team Cases Caroline Arquizan lapergue Bertrand, MD, PhD. Strong benefit of thrombectomy within 7 hrs in unlimitedly large core.NNT 4.Equal benefit in ASPECTS 0-2 vs 3-5 & lower mortality. No more reasons to exclude pts based on imaging !!


On Nov 3, Maryland Stroke Conference is excited and honored to have Tudor G. Jovin, MD as the keynote speaker. Keen to hear about “Current status and future directions of EVT in acute stroke treatment”. Many new developments to be aware of! Michael Phipps, MD, MHS @vcurrutiaMD Maryland Neurology Residency

Strong work by Karan Patel of Cooper Medical School of Rowan University & Jared Wolfe Pratit et al showing the growth of EVT after pivotal trials! Most growth in the souther stroke belt & teaching hospitals. Data highlight opportunities in other regions and systems 👇🏽 SVIN SNIS Info


What a joy to be able to hang out with Team Cooper at SVIN meeting in Miami Beach Cooper University Health Care Cooper Neurology Residency Jane Khalife Terri Yeager Neda Jafri Ahmad Ballout Renato Oliveira SVIN


Congrats Fawaz Al-Mufti, MD, FSVIN & Alexandra Czap for an outstanding job as #SVIN23 meeting chairs. Thank you for your distinguished service Ameer E. Hassan & Best Wishes to Thanh Nguyen 🇺🇦 as SVIN's new President. I am proud of SVIN accomplishments and optimistic about it's future !!



After thoughtful sparring with Adam Arthur MD MPH & Elad Levy over LASTE (thrombectomy shifts death to mRs 3),I wonder about the impact of SWITCH (hemicraniectomy shifts death to mRS 4) on neurosurgery practice.Should we ever offer it ? IMHO, selectively yes. thelancet.com/journals/lance…

Thank you Stavropoula Tjoumakaris MD, MBA, FAANS, FACS, FAHA and editorial staff at Endovascular Today for giving me the opportunity to share my thoughts, in tandem with the thoughtful May Nour, MD, PHD, FSVIN on the current state and future developments in ischemic stroke care. evtoday.com/articles/2024-…


I am humbled to have received the Lifetime Achievement Award at the SIMI 2024 conference of ENERI - Dr. Pedro Lylyk in the fabulous city of Buenos Aires, Argentina. A big thank you to Dr. Pedro Lylyk and his wonderful team for this great honor and for your amazing hospitality.


Check out our editorial just published in @JAMA. TESLA's unique feature is selection up to 24 hrs based on CT (ASPECTS 2-5) alone. Findings (including unpublished +ve results at 12 months) confirm that advanced imaging is not necessary even beyond 6 hrs. jamanetwork.com/journals/jama/…

